For the quarter ending 2025-09-30, NVNBW had -$500K decrease in cash & cash equivalents over the period. -$4,392K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -4,539 | -11,197 |
| Stock-based compensation | 688 | 2,095 |
| Depreciation and amortization | 31 | 74 |
| Amortization of right-of-use assets | 89 | 178 |
| Unrealized (gain) loss from investments | -39 | -273 |
| Prepaid expenses and other current assets | 85 | -119 |
| Accounts payable, accrued expenses and other current liabilities | -524 | 907 |
| Operating lease liabilities | -91 | -182 |
| Net cash used in operating activities | -4,392 | -7,733 |
| Maturities of investments | 13,546 | 24,835 |
| Purchase of property and equipment | 0 | 5 |
| Purchases of investments | 9,895 | 16,807 |
| Net cash provided by investing activities | 3,651 | 8,023 |
| Proceeds from stock option exercises | - | 0 |
| Proceeds from warrant exercises | 241 | - |
| Net cash provided by financing activities | 241 | 0 |
| Net increase (decrease) in cash and cash equivalents | -500 | 290 |
| Cash and cash equivalents at beginning of period | 1,754 | - |
| Cash and cash equivalents at end of period | 1,544 | - |
enVVeno Medical Corp (NVNBW)
enVVeno Medical Corp (NVNBW)